Supplements · Metabolic & Cardiometabolic
green tea improves glycemic control
In plain terms: Does green tea lower blood sugar?
Part of: 🧪 Green tea
Mixed and small. Diabetes trials are split — about half find nothing, half find a tiny fasting-glucose drop. A large population study links tea to less diabetes, but mostly because tea drinkers weigh less. Not a reliable blood-sugar tool.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Genuinely mixed. Meta-analyses of diabetes trials split roughly evenly — several find no significant effect on fasting glucose or HbA1c, a couple find a small fasting-glucose reduction (~1.4 mg/dL). A large UK Biobank cohort links tea to ~14% lower diabetes risk, but that's general tea, observational, and mostly explained by lower body weight.
The evidence (11)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Alves Ferreira M, Oliveira Gomes AP, Guimarães de Moraes AP, Ferreira Stringhini ML, Mota JF, Siqueira Guedes Coelho A, Borges Botelho P 2017 · Clin Nutr ESPEN | RCT | supports | moderate | RCT n=120 (overweight women): green tea extract FBG -4.4 mg/dL; nullified when combined with metformin. |
| Jia MJ, Liu XN, Liang YC, Liu DL, Li HL 2024 · Medicine (Baltimore) | meta-analysis | supports | low | Meta 15 RCTs (T2D): improved fasting glucose (SMD -0.41), HbA1c (SMD -0.68), HOMA-IR (SMD -0.70). |
| Liu K, Zhou R, Wang B, Chen K, Shi LY, Zhu JD, Mi MT 2013 · Am J Clin Nutr | meta-analysis | supports | high | Meta 17 RCTs (n=1133): FBG -0.09 mmol/L, HbA1c -0.30%. |
| Zheng XX, Xu YL, Li SH, Hui R, Wu YJ, Huang XH 2013 · Am J Clin Nutr | meta-analysis | mixed | high | Meta 22 RCTs (n=1584): FBG -1.48 mg/dL but NO HbA1c/insulin/HOMA-IR effect; glucose effect only >=12 wk. |
| Yu J, Song P, Perry R, Penfold C, Cooper AR 2017 · Diabetes Metab J | meta-analysis | contradicts | moderate | Meta 6 RCTs (prediabetes/T2D): no significant HbA1c, HOMA-IR, insulin, or fasting-glucose difference vs placebo. |
| Gan L, Zheng D, Zhao B, Yu K, Guo K, Hu G, Fang F, Zhou Z, Albanes D, Huang J 2025 · J Am Nutr Assoc | observational | supports | high | UK Biobank (n=382,946, 14 y): 4-5 cups/d tea - 14% lower T2D risk (HR 0.86), partly mediated by BMI (general tea, not green-specific). |
| Saadh MJ, Gataa IS, Hussam AS, Kaur I, Kumar A, Godara P, Zainul R, Muzammil K, Zahrani Y 2025 · Clin Ther | meta-analysis | supports | high | Meta 41 RCTs: EGCG lowered HbA1c -0.18%, FBG/HOMA-IR modestly; authors: likely not clinically meaningful. |
| Xu R, Bai Y, Yang K, Chen G 2020 · Nutr Metab (Lond) | meta-analysis | mixed | moderate | Meta 27 RCTs (n=2,194): fasting glucose -1.44 mg/dL (p<.001); no significant HbA1c or insulin effect. |
| Li Y, Wang C, Huai Q, Guo F, Liu L, Feng R, Sun C 2016 · Diabetes Metab Res Rev | meta-analysis | contradicts | moderate | Meta 10 RCTs (T2D): preserved fasting insulin but no significant fasting-glucose or HOMA-IR effect. |
| Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, Chou P 2011 · Altern Med Rev | RCT | contradicts | moderate | Double-blind placebo RCT, obese T2D adults (68 of 80 completed), 1,500 mg/d decaffeinated green tea extract (856 mg EGCG) x 16 wk: 'No statistically significant differences were detected between the decaffeinated GTE and placebo groups in any measured variable' (HOMA-IR primary; HbA1c, fasting glucose). Null on the directional claim -> contradicts. Abstract gives no between-group estimates or CIs, so precision is unknown. Within-group HbA1c 8.4 -> 8.0% in the GTE arm is not a randomised comparison. |
| Asbaghi O, Fouladvand F, Gonzalez MJ, Ashtary-Larky D, Choghakhori R, Abbasnezhad A 2021 · Diabetes Metab Syndr | meta-analysis | contradicts | moderate | Meta 14 RCTs (T2D): NO significant effect on fasting glucose, insulin, HbA1c, or HOMA-IR. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.